INS and hepatocellular carcinoma: In the univariate analysis from 2004 to 2013 after excluding participants with chronic viral hepatitis (952 HCC cases), the risk of incident HCC was still positively associated with use of insulin glargine and insulin detemir (OR, 1.49; 95% CI 1.06 to 2.10) (Table S3).